Glioma: all 1,425 studies
Page 9 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- A Study of DS-1001b in Patients With Chemotherapy- and Radiotherapy-Naive IDH1 Mutated WHO Grade II GliomaActive, not recruitingNCT04458272Phase 2
- Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsCompletedNCT04446416Not applicable
- Connectivity Alterations After Levetiracetam ApplicationStatus unknownNCT04425798
- Foci of Tumor Heterogeneity in Diffuse Low-Grade GliomasCompletedNCT04423094
- Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep LearningStatus unknownNCT04407039
- CAR-T Cell Immunotherapy for GD2 Positive Glioma PatientsWithdrawnNCT04406610Phase 1/2
- LY3214996 Plus Abemaciclib in Recurrent Glioblastoma PatientsCompletedNCT04391595Early Phase 1
- Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaCompletedNCT04388475Phase 2
- Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.Status unknownNCT04388033Phase 1/2
- Longitudinal MRI Assessment in Patients With Diffuse Low-grade GliomasCompletedNCT04346472
- Phase I Study of Marizomib + Panobinostat for Children With DIPGTerminatedNCT04341311Phase 1
- A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511TerminatedNCT04327011Phase 1
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsActive, not recruitingNCT04323046Phase 1
- Tumor Hypoxia and Proliferation in Patients With High-Grade GliomaSuspendedNCT04309552Phase 1
- Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade GliomaCompletedNCT04267146Phase 1/2
- CED of MTX110 Newly Diagnosed Diffuse Midline GliomasCompletedNCT04264143Phase 1
- Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade GliomasStatus unknownNCT04253873Phase 2
- Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)SuspendedNCT04222309Phase 1
- Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade GliomaWithdrawnNCT04220892Early Phase 1
- Glioma Patients Registry Based on Radiological, Histopathological and Genetic AnalysisStatus unknownNCT04220424
- Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive GlioblastomaActive, not recruitingNCT04214392Phase 1
- A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF AberrationActive, not recruitingNCT04201457Phase 1/2
- Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade GliomasActive, not recruitingNCT04197492Phase 2
- Biomarker-based Algorithm for Diagnosis of GliomaStatus unknownNCT04194593
- Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation TherapyActive, not recruitingNCT04186832Not applicable
- LITT Followed by Hypofractionated RT for Recurrent GliomasActive, not recruitingNCT04181684Not applicable
- Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.Active, not recruitingNCT04175301Phase 2
- D2C7-IT With Atezolizumab for Recurrent GliomasCompletedNCT04160494Phase 1
- Radiogenomic and Prognosis Analysis in GliomaStatus unknownNCT04122521
- Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With GliomaCompletedNCT04114370Early Phase 1
- Psychological Intervention For Brain Tumor CaregiversCompletedNCT04109209Not applicable
- Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With GlioblastomaCompletedNCT04091503Phase 1
- A Study of PRT811 in Participants With Advanced Solid Tumors, CNS Lymphoma and GliomasCompletedNCT04089449Phase 1
- Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade GliomaActive, not recruitingNCT04065776Not applicable
- Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for GliomasCompletedNCT04055688
- Gemcitabine in Newly-Diagnosed Diffuse Midline GliomaWithdrawnNCT04051047Early Phase 1
- Treatment Decision-making in Patients With Recurrent High-grade GliomaCompletedNCT04013828
- 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading GliomaCompletedNCT04001257
- Molecular Heterogeneity in Multilobar Low-grade GliomasStatus unknownNCT04000048
- Study of Olaparib and Durvalumab in IDH-Mutated Solid TumorsActive, not recruitingNCT03991832Phase 2
- The Effects of Mild Sedation on Motor Function Networks in Patients With Brian GliomasCompletedNCT03984240Not applicable
- Memory Perception Assessment in Central/Non-central Nervous System CancersCompletedNCT03975959Not applicable
- Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
- Remote Brain Microhaemorrhages May Predict Haematoma in Glioma Patients Treated With Radiation TherapyCompletedNCT03973892
- Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant GliomaWithdrawnNCT03973879Phase 1/2
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
- Resting-State Functional MRI in Glioma Patients Before and After SurgeryCompletedNCT03964909Not applicable
- Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant GliomasWithdrawnNCT03956706Not applicable
- Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR SpectroscopySuspendedNCT03952598Phase 2
- Efficacy of Kangliuwan for Recurrent Grade IV GliomaStatus unknownNCT03949192
- Cereset for CaregiversWithdrawnNCT03935269Not applicable
- First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of ProgressionStatus unknownNCT03932981Phase 2
- Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV GliomaTerminatedNCT03927274Early Phase 1
- Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade GliomasCompletedNCT03925246Phase 2
- Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaActive, not recruitingNCT03919071Phase 2
- Mindfulness Meditation in Glioma PatientsCompletedNCT03915912Not applicable
- Phase I Clinical Study of Oral TG02 Capsule in the Treatment of Recurrent / Progressive High-grade Glioma PatientsStatus unknownNCT03904628Phase 1
- Social Determinants of Health in Glioblastoma PopulationCompletedNCT03900689
- AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse GliomaCompletedNCT03893903Phase 1
- Fimepinostat in Treating Brain Tumors in Children and Young AdultsActive, not recruitingNCT03893487Early Phase 1
- Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification AlgorithmsCompletedNCT03877861
- Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma PatientsCompletedNCT03865355
- Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing GliomaTerminatedNCT03843814Not applicable
- Hypofractionated Radiotherapy for Recurrent DIPGCompletedNCT03841435Not applicable
- Early Temozolomide in Patients With High-Grade Gliomas in RehabilitationWithdrawnNCT03796507Early Phase 1
- Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesTerminatedNCT03796273Early Phase 1
- Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glioma at First RelapseCompletedNCT03779230Phase 1/2
- Glioma and ExercisingCompletedNCT03775369Not applicable
- Trial in Low Grade Glioma Patients: Wait or TreatTerminatedNCT03763422Phase 3
- Visual Study of Molecular Genotype in Glioma EvolutionStatus unknownNCT03750890
- BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV GliomasActive, not recruitingNCT03749187Phase 1
- TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCTStatus unknownNCT03741244Phase 2
- Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
- Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant GliomaCompletedNCT03722355Phase 3
- Feasibility of the LUM Imaging System for Detection of Cancer to the BrainTerminatedNCT03717142Not applicable
- Multimodal Imaging of Hypoxia in GliomasStatus unknownNCT03716986Not applicable
- Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline GliomasCompletedNCT03696355Phase 1
- Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015Status unknownNCT03690570
- Feasibility of Individualized Therapy for Recurrent GlioblastomaCompletedNCT03681028Phase 1
- 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
- Spectroscopic Magnetic Resonance Imaging of GliomaWithdrawnNCT03677999
- Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 MutationActive, not recruitingNCT03666559Phase 2
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsWithdrawnNCT03649464Phase 1/2
- Awake Intraoperative Language Mapping and Chinese Probabilistic Map ConstructionStatus unknownNCT03641391Not applicable
- EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsCompletedNCT03638167Phase 1
- A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With GliomasWithdrawnNCT03632317Phase 2
- Awake vs. Asleep Craniotomy for Non-eloquent GliomasCompletedNCT03621748Not applicable
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade GliomaActive, not recruitingNCT03605550Phase 1
- A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent GliomasTerminatedNCT03593993
- GMCI, Nivolumab, and Radiation Therapy in Treating Patients with Newly Diagnosed High-Grade GliomasCompletedNCT03576612Phase 1
- Olaparib in Recurrent IDH-mutant GliomaCompletedNCT03561870Phase 2
- Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionCompletedNCT03551249Not applicable
- Intraoperative Ultrasound Guided Glioma Surgery; a Randomised, Controlled Trial.Status unknownNCT03531333Not applicable
- Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaCompletedNCT03514069Phase 1
- Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating FieldsCompletedNCT03501134
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsActive, not recruitingNCT03500991Phase 1
- Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages FluentlyCompletedNCT03496181
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- Early Palliative Care Intervention in Malignant GliomaCompletedNCT03471546Not applicable
- Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)Status unknownNCT03463733Phase 1